v181
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 15, 2023 (NCT05710224)
Timeline
Indications
Studied for
Mechanism of action
- Dengue virusImmunity, active
Dengue virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07013487 | Phase 3 | Jun 11, 2025 | Merck |
| NCT05710224 | Phase 2 | Feb 15, 2023 | Butantan Institute, Merck |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 2 | 1 | 2 | 2023 |
| Butantan Institute | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1